C

Click Therapeutics

Develops FDA-cleared prescription digital therapeutics

Senior Associate of Business Development

Business Development & PartnershipsPosted on Nov 10
Full-timeNew York, NY, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • Two to five years of business development, alliance management, or investment banking experience in life sciences is required.
  • Ability to self-manage deadlines, prioritize assignments, and deliver detailed outputs is required.
  • Ability to work independently and learn quickly is required.
  • Relationship-management capability is required.
  • Adaptability to changing requirements and scope is required.
  • Strong written and verbal communication skills are required.
  • Applicants must have authorization to work in the United States.

Responsibilities

  • Identify, evaluate, and drive business development opportunities aligned with the organization's strategic, therapeutic, and commercial needs.
  • Partner with legal and other internal functional teams to lead negotiations.
  • Manage a pipeline of partnering opportunities and timelines, coordinate cross-functional collaboration, and deliver high-quality outputs.
  • Create presentations and materials for partnering discussions.
  • Cultivate relationships with potential partners in relevant industries.
  • Develop business cases covering opportunities, rationale, timelines and resources, risks, and considerations to optimize the partnering strategy.
  • Lead due diligence processes.
  • Support other prioritized business development initiatives and activities as needed.

Desired Qualifications

  • Experience working in a lean or startup environment.
  • Experience in digital therapeutics or traditional pharmacotherapy.

About the Company

Click Therapeutics

Develops FDA-cleared prescription digital therapeutics

Click Therapeutics creates prescription software to treat health conditions with digital therapeutics. Its products are software applications that can be used as medicines alone or with traditional treatments, designed to affect cognitive and neurobehavioral processes underlying diseases. They are developed and validated through randomized controlled trials and pursue FDA clearance to market them as class II medical devices. Revenue comes from physicians who prescribe the apps and payers who reimburse them, with real-world evidence used to refine and personalize the software. A notable collaboration with Boehringer Ingelheim aims to develop a $500 million prescription digital therapeutic for schizophrenia. The leadership includes CEO David B. Klein and C-suite officers, with a focus on bringing clinically validated digital health solutions to patients who have unmet medical needs.

Company size
51-200
Company stage
Series D
Total funding
$211.6M
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Click Therapeutics

See more jobs